GlassScriptPhysician profile
Brandon M Blount
NPI 1215558424
$730.36
in general payments reported to CMS, 2019-2025
10 companies · $316 in 2025
The $316 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $290 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.98 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $354.30 | 2024-2025 | Tezspire |
| Glaxosmithkline, LLC. | $125.00 | 2023 | Nucala |
| Vertex Pharmaceuticals Incorporated | $53.29 | 2024-2025 | |
| Insmed, INC. | $36.39 | 2025 | Arikayce |
| Baxter Healthcare | $36.13 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Aimmune Therapeutics, INC. | $35.52 | 2024-2025 | Zenpep |
| Alcresta Therapeutics, INC. | $29.04 | 2024 | Relizorb |
| Mylan Specialty L.P. | $22.15 | 2024 | Tobi Podhaler |
| Astrazeneca Pharmaceuticals LP | $19.65 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.89 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Blount listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.